|
시장보고서
상품코드
2091391
난시 시장 규모, 점유율, 성장 분석 : 치료법별, 난시 종류별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Astigmatism Market Size, Share, and Growth Analysis, By Treatment Type (Corrective Eyeglasses, Contact Lenses), By Astigmatism Type (Myopic Astigmatism, Hyperopic Astigmatism), By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 난시 시장 규모는 2024년에 147억 3,000만 달러로 평가되었으며, 2025년 156억 1,000만 달러에서 2033년까지 248억 9,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 6.0%로 성장할 것으로 전망됩니다.
세계 난시 시장은 시력상의 원주 굴절 이상을 진단, 교정 및 관리하기 위한 제품과 서비스에 초점을 맞추고 있습니다. 시력에 영향을 미치는 질환의 유병률 증가는 생산성과 전반적인 삶의 질에 막대한 영향을 미치고 있으며, 전 세계적으로 수백만 명에게 영향을 주고 있습니다. 이 시장은 젊은 층에서 근시 관련 난시 사례가 증가하고, 고령화에 따라 교정 렌즈 및 외과적 치료법에 대한 수요가 높아짐에 따라 눈부신 성장을 이루고 있습니다. 광간섭 단층촬영(OCT) 등의 첨단 기술 도입으로 조기 발견이 가능해졌으며, 이는 제약 및 의료기기 부문 전체의 성장을 주도하고 있습니다. 특히 레이저 보조 굴절 교정 수술을 비롯한 프리미엄 솔루션의 도입 확대와 원격 안과 진료 플랫폼의 결합을 통해 접근성이 향상되고, 더 폭넓은 환자층에 대한 진료가 확대되면서 시장의 호조세가 유지되고 있습니다.
세계 난시 시장의 성장요인
세계 난시 시장의 확대는 난시 유병률의 증가에 큰 영향을 받고 있으며, 그 주요 요인으로는 고령화, 화면 사용 시간의 증가, 눈 건강에 대한 관심 고조 등을 들 수 있습니다. 난시에 대한 인식이 높아짐에 따라 효과적인 교정 솔루션을 찾는 사람들이 늘어나고 있으며, 이에 따라 의료 서비스 제공자들은 서비스 범위를 확대하고 있습니다. 이는 결과적으로 제조사의 기술 혁신을 촉진하여, 다양한 렌즈와 수술 옵션의 개발로 이어지고 있습니다. 수요 증가가 시장 성장을 뒷받침하고 있으며, 연구, 유통, 교육 활동에 대한 투자를 촉진하고 있는데, 이 모든 요소가 안과 분야의 기술 보급 확대와 지속적인 제품 개선에 기여하고 있습니다.
세계 난시 시장의 제약요인
레이저 치료나 토릭 인공수정체 삽입과 같은 고도의 난시 교정 치료에 따르는 고액의 비용은, 특히 개발도상국에서 많은 환자들에게 큰 장벽이 되고 있습니다. 이러한 고액의 비용은 많은 사람들이 이러한 서비스를 이용하는 것을 주저하게 만드는 요인이 되고 있으며, 시장의 성장은 경제적으로 여유가 있는 계층이나 보험 가입이 탄탄한 계층으로 한정되어 있습니다. 또한, 의료 서비스 제공자들은 비용 대비 효과가 높은 대안을 선호하는 경향이 있어, 그 결과 고가의 외과적 시술에 대한 수요가 감소하고 있습니다. 이러한 가격에 대한 민감성은 시장 전체의 발전을 저해하고 있으며, 제조사들은 종합적인 보험 환급 제도가 마련되지 않은 상황에서는 판매망 확대나 투자의 지속가능성을 입증하기가 어려워지고 있습니다. 또한, 레이저 기기의 지속적인 유지보수는 엄격한 예산 제약 하에서 운영되는 진료소에 있어 지속적인 재정적 부담이 되고 있습니다.
세계 난시 시장의 동향
세계 난시 시장에서는 안과 진단에 인공지능(AI)을 접목하는 것을 원동력으로 삼아 큰 변화가 일어나고 있습니다. AI를 활용한 영상 진단 도구는 난시의 정확한 검출 및 정량화를 가능하게 하며, 임상의에게 각막 토포그래피에 대한 거의 실시간에 가까운 분석 결과를 제공합니다. 고도의 기계 학습 알고리즘을 채택한 이러한 도구들은 방대한 환자 데이터를 통해 곡률 모델을 정교화하고, 주관적인 해석을 최소화하며, 교정용 렌즈 및 굴절 교정 수술의 치료 계획을 최적화합니다. 이러한 기술이 보급됨에 따라 업무 흐름의 효율이 향상되고, 진료 시간이 단축되며, 환자의 신뢰가 높아짐에 따라 전 세계 다양한 안과 의료 현장에서 혁신적인 시력 교정 솔루션이 널리 받아들여지고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 난시 시장 규모 : 치료 유형별
세계의 난시 시장 규모 : 난시 종류별
세계의 난시 시장 규모 : 최종사용자별
세계의 난시 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.07.23Global Astigmatism Market size was valued at USD 14.73 Billion in 2024 and is poised to grow from USD 15.61 Billion in 2025 to USD 24.89 Billion by 2033, growing at a CAGR of 6.0% during the forecast period (2026-2033).
The global astigmatism market focuses on products and services aimed at diagnosing, correcting, and managing cylindrical refractive errors in vision. The increasing prevalence of conditions affecting visual acuity has a profound influence on productivity and overall quality of life, impacting millions globally. The market has experienced considerable growth due to rising cases of myopia-related astigmatism in younger populations and heightened demand for corrective lenses and surgical options from an aging demographic. The integration of advanced technologies such as optical coherence tomography facilitates earlier detection, driving growth across pharmaceutical and device sectors. Increasing adoption of premium solutions, especially laser-assisted refractive surgery, combined with tele-ophthalmology platforms, enhances accessibility, extending care to wider patient populations and sustaining positive market momentum.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Astigmatism market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Astigmatism Market Segments Analysis
Global astigmatism market is segmented by treatment type, astigmatism type, end user and region. Based on treatment type, the market is segmented into Corrective Eyeglasses, Contact Lenses, Refractive Surgery and Toric Intraocular Lenses (IOLs - for cataract patients). Based on astigmatism type, the market is segmented into Myopic Astigmatism, Hyperopic Astigmatism and Mixed Astigmatism. Based on end user, the market is segmented into Hospitals, Optometry & Specialty Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Astigmatism Market
The expansion of the global astigmatism market is significantly influenced by the increasing prevalence of astigmatism, largely attributed to factors such as aging populations, greater screen time, and an enhanced focus on eye health. As awareness of astigmatism grows, more individuals are seeking effective corrective solutions, which encourages healthcare providers to broaden their range of services. This, in turn, motivates manufacturers to innovate, leading to a diverse array of lenses and surgical options. The rising demand bolsters market growth and stimulates investments in research, distribution, and educational initiatives, all of which contribute to increased adoption and ongoing product advancements in the ophthalmic sector.
Restraints in the Global Astigmatism Market
The high costs associated with advanced astigmatism correction procedures, such as laser-assisted treatments and toric intraocular lens implantation, present a substantial hurdle for numerous patients, especially in developing regions. These elevated expenses deter many from accessing these services, confining market growth to wealthier demographics or those with robust insurance coverage. Additionally, healthcare providers often lean towards more cost-effective options, which diminishes the demand for premium surgical interventions. This price sensitivity hampers overall market development, as manufacturers face difficulties in expanding distribution and demonstrating the sustainability of their investments without extensive reimbursement frameworks. Moreover, continuous maintenance of laser equipment introduces ongoing financial strains for clinics operating under tight budget constraints.
Market Trends of the Global Astigmatism Market
The global astigmatism market is witnessing a significant shift driven by the integration of artificial intelligence in ophthalmic diagnostics. AI-enhanced imaging tools facilitate the precise detection and quantification of astigmatism, providing clinicians with near-real-time analysis of corneal topography. By employing advanced machine-learning algorithms, these tools refine curvature models through extensive patient data, minimizing subjective interpretation and optimizing treatment planning for corrective lenses and refractive surgeries. As these technologies gain traction, they enhance workflow efficiency, decrease appointment times, and bolster patient confidence, thereby fostering widespread acceptance of innovative corrective solutions across diverse eye-care settings worldwide.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Astigmatism Market Size by Treatment Type & CAGR (2026-2033)
- Market Overview
- Corrective Eyeglasses
- Contact Lenses
- Soft Toric Contact Lenses
- Rigid Gas-Permeable (RGP) Lenses
- Hybrid Contact Lenses
- Refractive Surgery
- LASIK
- SMILE
- PRK (Photorefractive Keratectomy)
- Toric Intraocular Lenses (IOLs - for cataract patients)
Global Astigmatism Market Size by Astigmatism Type & CAGR (2026-2033)
- Market Overview
- Myopic Astigmatism
- Hyperopic Astigmatism
- Mixed Astigmatism
Global Astigmatism Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Optometry & Specialty Clinics
- Ambulatory Surgical Centers
Global Astigmatism Market Size & CAGR (2026-2033)
- North America (Treatment Type, Astigmatism Type, End User)
- US
- Canada
- Europe (Treatment Type, Astigmatism Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Treatment Type, Astigmatism Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Treatment Type, Astigmatism Type, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Treatment Type, Astigmatism Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alcon Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson Vision Care Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bausch + Lomb Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CooperVision Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Essilor Luxottica SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HOYA Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Carl Zeiss Meditec AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Staar Surgical Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Topcon Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NIDEK Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Haag-Streit Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orion Vision Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SeaVision USA Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Medical Optics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sightsavers International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Visionix Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Icare Finland Oy
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Welch Allyn (Hillrom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Canon Medical Systems Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
